Not checkedNot checked for notices yet.
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates
Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan and 27 more
Nature Communications · 2022
doi:10.1038/s41467-022-30835-1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
There is limited real-world evidence for the effectiveness of the BBIBP-CorV (Sinopharm) vaccine against severe COVID-19 disease. Here, the authors use data from Abu Dhabi and estimate effectiveness at 80% against hospitalization; 86% against critical care admission and 84% against death.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.